These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Proteomic approaches and identification of novel therapeutic targets for alcoholism. Gorini G; Harris RA; Mayfield RD Neuropsychopharmacology; 2014 Jan; 39(1):104-30. PubMed ID: 23900301 [TBL] [Abstract][Full Text] [Related]
7. A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction. Bell RL; Hauser S; Rodd ZA; Liang T; Sari Y; McClintick J; Rahman S; Engleman EA Int Rev Neurobiol; 2016; 126():179-261. PubMed ID: 27055615 [TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapies for alcoholism: the old and the new. Olive MF CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494 [TBL] [Abstract][Full Text] [Related]
9. New horizons for therapeutics in drug and alcohol abuse. Jupp B; Lawrence AJ Pharmacol Ther; 2010 Jan; 125(1):138-68. PubMed ID: 19917308 [TBL] [Abstract][Full Text] [Related]
10. Investigational drugs for alcohol use disorders: a review of preclinical data. Ch'Ng SS; Lawrence AJ Expert Opin Investig Drugs; 2018 May; 27(5):459-474. PubMed ID: 29723484 [TBL] [Abstract][Full Text] [Related]
11. Cholinergic receptor system as a target for treating alcohol abuse and dependence. Rahman S; Prendergast MA Recent Pat CNS Drug Discov; 2012 Aug; 7(2):145-50. PubMed ID: 22574675 [TBL] [Abstract][Full Text] [Related]
12. Novel medication targets for the treatment of alcoholism: preclinical studies. Rezvani AH; Lawrence AJ; Arolfo MP; Levin ED; Overstreet DH Recent Pat CNS Drug Discov; 2012 Aug; 7(2):151-62. PubMed ID: 22574676 [TBL] [Abstract][Full Text] [Related]
13. Advancing Pharmacotherapy Development from Preclinical Animal Studies. Egli M Handb Exp Pharmacol; 2018; 248():537-578. PubMed ID: 29374834 [TBL] [Abstract][Full Text] [Related]
14. Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence. Leggio L; Cardone S; Ferrulli A; Kenna GA; Diana M; Swift RM; Addolorato G Curr Pharm Des; 2010; 16(19):2159-18. PubMed ID: 20482506 [TBL] [Abstract][Full Text] [Related]
15. Neurochemical Evidence of Preclinical and Clinical Reports on Target-Based Therapy in Alcohol Used Disorder. Prajapati SK; Bhaseen S; Krishnamurthy S; Sahu AN Neurochem Res; 2020 Feb; 45(2):491-507. PubMed ID: 31898084 [TBL] [Abstract][Full Text] [Related]
16. Translational studies of alcoholism: bridging the gap. Zahr NM; Sullivan EV Alcohol Res Health; 2008; 31(3):215-30. PubMed ID: 20041042 [TBL] [Abstract][Full Text] [Related]
17. Preclinical and clinical pharmacology of alcohol dependence. Tambour S; Quertemont E Fundam Clin Pharmacol; 2007 Feb; 21(1):9-28. PubMed ID: 17227441 [TBL] [Abstract][Full Text] [Related]
18. Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders. Freeman WM; Vrana KE Alcohol Clin Exp Res; 2010 Jun; 34(6):946-54. PubMed ID: 20374220 [TBL] [Abstract][Full Text] [Related]
19. Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics. Johnson BA; Swift RM; Ait-Daoud N; DiClemente CC; Javors MA; Malcolm RJ Alcohol Clin Exp Res; 2004 Feb; 28(2):295-301. PubMed ID: 15112937 [TBL] [Abstract][Full Text] [Related]